JMPWA
DRTX

JP Morgan Private Wealth Advisors’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,000
Closed -$135K – 949
2014
Q1 		$135K Hold
10,000
– – ﹤0.01% 838
2013
Q4 		$128K Hold
10,000
– – ﹤0.01% 637
2013
Q3 		$90K Buy
+10,000
New +$82.9K ﹤0.01% 622

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Private Wealth Advisors's DRTX Position: Q2 2014 in Review

JP Morgan Private Wealth Advisors sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q2 2014, closing a stake of 10,000 shares — an estimated $135K sold.

JP Morgan Private Wealth Advisors first reported a position in DRTX in Q3 2013 and held it in 3 quarters. The position peaked at $135K in Q1 2014. 74 funds tracked by Wall St. Rank hold DRTX as of Q2 2014.

  • JP Morgan Private Wealth Advisors reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 10,000 DURATA THERAPEUTICS INC COM STK (DE) shares in Q2 2014, an estimated $135K.
  • JP Morgan Private Wealth Advisors first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 3 quarters.
  • JP Morgan Private Wealth Advisors's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $135K in Q1 2014.
  • 74 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q2 2014.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2014, filed 11 Aug 2014.